Harbin Fuerjia Technology Co., Ltd. (SHE:301371)
China · Delayed Price · Currency is CNY 24.88
-0.29 (-1.15%)
At close: Feb 13, 2026
Harbin Fuerjia Technology Revenue
Harbin Fuerjia Technology had revenue of 434.04M CNY in the quarter ending September 30, 2025, a decrease of -17.58%. This brings the company's revenue in the last twelve months to 1.85B, down -10.32% year-over-year. In the year 2024, Harbin Fuerjia Technology had annual revenue of 2.02B with 4.32% growth.
Revenue (ttm)
1.85B
Revenue Growth
-10.32%
P/S Ratio
7.00
Revenue / Employee
2.61M
Employees
707
Market Cap
12.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.02B | 83.47M | 4.32% |
| Dec 31, 2023 | 1.93B | 164.29M | 9.29% |
| Jan 1, 2023 | 1.77B | 119.53M | 7.25% |
| Dec 31, 2021 | 1.65B | 64.67M | 4.08% |
| Dec 31, 2020 | 1.59B | 242.55M | 18.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bank of Lanzhou | 4.39B |
| Miracle Automation Engineering Co.Ltd | 2.84B |
| Shenzhen Leaguer | 2.39B |
| Pacific Shuanglin Bio-pharmacy | 2.38B |
| Yangling Metron New Material | 1.90B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| DR Corporation | 1.53B |
| Eastcompeace Technology Co.Ltd | 1.28B |